Atlas Trials

A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake

Clinical trial NCT02128581 · COMPLETED

Trial details

NCT number
NCT02128581
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ObesityDiabetesRoux-en-Y Gastric Bypass
Start date
2014-05-01
Primary completion
2016-03-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.